Industry / Thailand
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
GPO Rejects Input From Private Sector
April 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
BMI estimates that over 95% of global pharmaceutical sales are made by private enterprises, and predicts that this figure will increase in the future. State-run drugmakers are an anachronism in the modern capitalist age and are either being privatised or shut down. However, there are still several examples across the world. Thailand's Government Pharmaceutical Organisation (GPO) is one that is resisting the